BIMEDA ANIMAL HEALTH, a global animal health company, is offering a position for an Industry Swine Veterinarian in the United States. For a complete description, please see the attached link: https://hcrx.fa.em2.oraclecloud.com/hcmUI/CandidateExperience/en/sites/CX/job/10825.
Monthly Archives: June 2021
Leman Swine Conference – Research Abstracts Due July 7
Submit your research abstract for the Allen D. Leman Swine Conference, September 18-21, 2021. Abstracts for posters and oral presentations can be submitted online through July 7, 2021.
New CE To Help Build Inclusive Team and Practice – AVMA Brave Space Certificate Program in Diversity, Equity, and Inclusion
Experience AVMA’s newest interactive multi-module CE offering, the Brave Space Certificate Program. The self-paced course consists of 7 modules exploring critical topics including stereotyping, unconscious bias, workplace harassment, interpersonal violence, racism, and more. Participants will come away with practical tools and strategies to make your practice a Brave Space – one in which everyone is seen and appreciated, from team members, to patients and clients, to the communities we serve.
Position Announcement: Swine Technical Services Veterinarian
Cambridge Technologies, a rapidly growing precision diagnostics and custom vaccine company dedicated to serving veterinarians and livestock producers, is seeking an experienced, full-time Swine Technical Services Veterinarian. In collaboration with account managers, the successful candidate will provide technical support to swine veterinarians and producers regarding clinical cases, diagnostics, selection of isolates, and appropriate use of autogenous biologicals. Our unique offering to our customers combines experienced staff with leading-edge technology to best fill their needs. This role will require 80% travel, including overnight travel as needed. We offer an excellent compensation and benefits package including 401(k). The full job description and online application can be found on our website at www.cambridgetechnologies.com. Position open until filled. EOE
Practice Tips: Learn from the past and shape our future
AASV members can shape the future of our profession by offering practical advice to colleagues in the Practice Tips session at the Annual Meeting. Every year several members share an insight or strategy that has worked for them in the past. Now it’s your turn! We need you to share your experience at the 2022 AASV Annual Meeting in Indianapolis, Indiana. Practice tip presentations are only 10 minutes in length and no abstract is required! Prizes will be awarded for the top presenters. Please contact Melissa Billing (melissa.billing@boehringer-ingelheim.com) or the AASV office (aasv@aasv.org) to sign up!
Committee Shoat Out: Nutrition Committee
Committee Shoat Out: The Nutrition Committee recommends a nutrition preconference seminar during the 2022 AASV Annual Meeting to be held in Indianapolis, IN, February 26-March 1, 2022.
Evaluation of a Warfarin Bait for Controlling Invasive Wild Pigs (Sus scrofa)
Background: Wild pigs (Sus scrofa) cause widespread environmental and economic damage, and as a result are subjected to extensive control. Current management strategies have proven insufficient, and there is growing interest in use of toxicants to control invasive populations of this species. In 2017 a low-dose warfarin bait was federally approved for use in controlling wild pigs in the United States. However, no states have allowed use of this bait due to unanswered questions regarding welfare concerns, field efficacy, and non-target impacts. Results: All captive wild pigs fed 0.005% warfarin baits in no choice feeding trials succumbed in an average of 8 days from exposure. Behavioral symptoms of warfarin exposure included vomiting, external bleeding, abnormal breathing, incoordination, and limping. Postmortem examinations revealed hemorrhaging in organs and muscles, particularly the legs, gastrointestinal tract, and abdomen. Warfarin residues in tissues averaged 1.0 mg kg-1 for muscle, 3.9 mg kg-1 for liver, and 2.8 mg kg-1 for small intestines. Field testing revealed wild pigs required extensive training to access bait within pig-specific bait stations, and once acclimated, exhibited reluctance to consume toxic baits, resulting in no mortalities across two separate field deployments of toxic bait. Conclusion: Our results suggest wild pigs are susceptible to low-dose warfarin, and warfarin residues in pig tissues postmortem are generally low. However, although warfarin-based baits are currently approved for use by the US Environmental Protection Agency, further improvements to pig-specific bait delivery systems and bait palatability are needed, as well as additional research to quantify efficacy, cost, and non-target impacts prior to widespread implementation. © 2021 Society of Chemical Industry. This article has been contributed to by US Government employees and their work is in the public domain in the USA. Beasley J, Clontz L, Rakowski A, Snow N, VerCauteren K. Evaluation of a warfarin bait for controlling invasive wild pigs (Sus scrofa). Pest Manag Sci. 2021 Jul. https://doi.org/10.1002/ps.6351
Mycoplasma hyopneumoniae Genetic Variability within Swine Production Flows
The aim of this study was to assess the genetic variability of Mycoplasma hyopneumoniae within various swine production flows. Four M. hyopneumoniae positive production flows, composed of 4 production stages, were selected for this study. Laryngeal and/or bronchial swabs were collected from each production stage within a flow, for a period of 4 months up to 3 years. A multiple-locus variable-number tandem repeat analysis was performed to assess the genetic variation of M. hyopneumoniae within and across production flows through the identification of variable-number tandem repeat (VNTR) types. A maximum of 6 M. hyopneumoniae VNTR types were identified in a single flow, in which VNTR types appeared to be flow specific. An identical VNTR type was detected across several production stages for up to 3 years. In this study, minimal M. hyopneumoniae genetic variation was evidenced within and across production flows. Betlach A, Fano E, Sponheim A, Valeris-Chacin R, Dalquist L, Singer R, Pieters M. Comparison of Mycoplasma hyopneumoniae genetic variability within swine production flows. Can J Vet Res. 2020 Oct. http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7490998/
SHIC Pursues Information on Novel Rotavirus to Determine Risk to US Swine Herd
The Swine Health Information Center (SHIC) monitors emerging swine disease threats, engaging experts on preparedness, response, and possible actions needed on behalf of the US pork industry. Recently, SHIC inquired with experts regarding a novel rotavirus affecting foals in Kentucky this spring. After consideration, those experts, Drs. Feng Li, University of Kentucky (UK) Gluck Equine Research Center, along with swine experts Albert Rovira, University of Minnesota, Ben Hause, South Dakota State University, and Eric Burrough, Iowa State University, conferred with SHIC and determined there was no need for action as the virus was not a threat to pork production.
USDA Adds Blood Swabs and Spots as Official ASF Testing Tissues
The Swine Health Information Center (SHIC) learned the USDA has approved blood swabs and spots as samples for official African swine fever (ASF) testing during foreign animal disease (FAD) investigations. These are an important addition to antemortem samples previously approved since August 2018; the full list of approved samples includes whole blood, tonsil, spleen, lymph node, spleen swabs, blood swabs and blood spots. While important additions, more work needs to be done to fully integrate blood swabs and blood spots into the ASF/CSF active surveillance program as well as the ASF Red Book. The process is ongoing. SHIC will continue to monitor developments and share progress with stakeholders interested in ASF testing protocols.